Hetero Labs could launch its generic sleep disorder drug as early as 2040 under a settlement deal with Axsome Therapeutics.

Novartis won a bidding war against a fellow large drugmaker to acquire Regulus Therapeutics, according to a regulatory filing ...

FDA leaders Makary, Prasad & Brenner will visit six US cities in June/July for discussions on regulatory modernization.

Sernova chairman Ross Haghighat resigns after DOJ indictment on 16 insider trading counts related to Novartis' $3.2B Chinook Therapeutics acquisition in 2023.

Boundless Bio halts BBI-355 monotherapy & combinations due to toxicity, shifts to BBI-355/BBI-825 combo. Cuts 33% of staff to ...

Eli Lilly is deepening its presence in the non-opioid pain field by buying California biotech SiteOne Therapeutics, which is ...

The FDA approved Liquidia’s treprostinil program for two related kinds of high blood pressure, turning up the heat on rival ...

Plus, news about Lexeo, TreeFrog Therapeutics, Hansa Biopharma, AbbVie, Elpiscience Biopharmaceuticals, Immutep, Hedera Dx, ...

Bio­gen is div­ing in­to the RNAi field with City Ther­a­peu­tics, a biotech led by sev­er­al for­mer Al­ny­lam lead­ers.

Trials for mental health drugs sometimes fail not because the medicine does not work, but because the measure of its effects is unreliable. Brooklyn Health’s technology aims to change that, and share ...

Angelini will pay $50 million upfront and up to $520 million in biobucks to Grin for the ex-North America rights to ...

Rocket Pharmaceuticals said Tuesday morning that a patient in its gene therapy trial for Danon disease died after an 'acute ...